|
|  | West DeconSide
Effects:
May cause drowsiness, dizziness, headache, loss of appetite, stomach upset, blurred
vision, restlessness, irritability and dry mouth and nose.
These effects
should subside as your body adjusts to the medication. If they persist
or become bothersome, inform your doctor. Notify your doctor if you develop
breathing difficulties, heart pounding, irregular heartbeat, chest pain, ringing
in the ears, or difficulty urinating while taking this medication. May
cause dizziness especially when rising quickly from a seated or lying position.
Change positions slowly and be careful on stairs. Use caution engaging
in activities requiring alertness.
Precautions:
If you have asthma, glaucoma, an ulcer, difficulty urinating due to an enlarged
prostate gland, heart disease, high blood pressure, seizures, or an overactive
thyroid gland, do not use this drug unless your doctor is aware of your medical
condition.
This drug should be used only if clearly needed during pregnancy.
Consult your doctor before breast-feeding. Check other medicines
you take for duplications. Do not drink alcoholic beverages. Do
not give extended-release tablets to a child younger than 12 years of age unless
directed to do so by a doctor. Generic Name: Phenyleph HCl/PP HC/P-Tlox/CPRelated:
Naldecon Pediatric Drops - Prescription
New Decongestant Pediatric Drops - Prescription
Tri-Phen-Mine Pediatric Drops - Prescription
Tri-Phen-Chlor Pediatric Drops - Prescription
Nalphen Pediatric Drops - Prescription
Andecon Pediatric Drops - Prescription
Naldecon Syrup - Prescription
Naldecon Tablet, Sustained Action - Prescription
West Decon Tablet, Sustained Action - Prescription
Tri-Phen-Mine Tablet, Sustained Action - Prescription
Tri-Phen-Chlor Tablet, Sustained Action - Prescription
Uni-Decon Tablet, Sustained Action - Prescription
Nalgest Tablet, Sustained Action - Prescription
Naldecon Pediatric 1-2 Syrup - Prescription
New Decongestant Pediatric 1-2 Syrup - Prescription
Tri-Phen-Mine Pediatric 1-2 Syrup - Prescription
Tri-Phen-Chlor Pediatric 1-2 Syrup - Prescription
Nalphen Pediatric 1-2 Syrup - Prescription

rightplanformulary2003http://www.bluecrossca.com/pdf/Pharmacy/rightplanformulary2003.pdf
drug, generics, INSULIN, brand, medications, CODEINE, HYDROCORTISONE, SULFATE,
Blue Cross, lists, ERYTHROMYCIN. Until the patent expires,
no other companies can produce that same particular brand name drug which keeps
the price relatively high.
Generics may differ from their brand name equivalent
in color and or shape.
In order to minimize the potential for adverse
drug reactions due to over utilization, Blue Cross has implemented an upper dispensing
limit on select medications.
The quantity limits adopted by Blue Cross
should allow for a medically appropriate quantity for most conditions.
However, if your doctor has determined that it is medically necessary for you
to take a larger amount, please ask your doctor to submit a prior authorization
of benefits request to have the additional amount reviewed for coverage.
The first column lists the brand name or common name of a given drug, and is for
reference purposes only.
2004SeniorSecureFormularyhttp://www.bluecrossca.com/Medicar2004SeniorSecureFormulary.pdf
Tablet, HCL, Capsule, GUAIFENESIN, Syrup, HYDROCORTISONE, Liquid, SULFATE, Cream,
Suspension, Ointment. Blue Cross Senior Secure is an
HMO with a Medicare+Choice contract.
To be accepted into Blue Cross Senior
Secure, you must maintain Part A of Medicare and must continue to pay your Part
B premiums.
The Prescription Drug Formulary is a list of generic, preferred
brand and brand name drugs covered by your Blue Cross Senior Secure plan.
same amounts as the brandname drug.Like brand-name medications, generic drugs
undergo the same rigorous FDA quality and safety reviews.As a result, generics
are safe and effective alternatives to brand name medications.
POTASSIUM
BICARBONATE POTASSIUM BICARBONATE/CIT AC Tablet Effer.
POTASSIUM CHLORIDE
POT CHLORIDE/POT BICARB/CIT AC Tablet Effer.
2000-01_Formulary
treatment, Sulfate, agents, therapy, Exempt, HCL, patients, failure, sodium, drugs,
dosage. Approval for use of drugs for conditions not
meeting the IEHP approved Code 1 requirements for use may be obtained by submitting
a Pharmacy Exception Request (PER) form.
Prescriptions for drugs not listed
in the IEHP Formulary and drugs for medical conditions not listed under Code 1
restrictions require prior authorization before reimbursement can be made.
Fluconazole: restricted to use in cancer patients or in patients with AIDS or
AIDS-related conditions and only for the indication and usage as specified in
the package insert for the drug product.
Ketoconazole: restricted to use
after failure of first line treatment; topical preparation restricted to use after
first line treatment failure (clotrimazole, miconazole, nystatin and tolnaftate
are first line choices).
|